Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04197453 · ClinicalTrials.gov registry record
The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)
A clinical trial, sponsored by Amgen.
- Terminated
- Registry status
- 752
- Enrollment target
NCT04197453 is a clinical trial that was terminated before completion, run by Amgen. The registered enrollment target is 752 participants.
The verdict
NCT04197453 was terminated before completion, sponsored by Amgen.
- TERMINATED
- Registry status
- 752 participants
- Enrollment target
Study Summary
cvMOBIUS is a North American registry of patients with ASCVD aimed at understanding patterns of care in ASCVD while evaluating the real world effectiveness of PCSK9 inhibitors.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 752 participants |
| Start Date | 2019-12-06 |
| Est. Completion | 2020-12-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04197453
The ClinicalTrials.gov registry entry for NCT04197453 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 752 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04197453 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04197453 about?
NCT04197453 is a clinical study titled "The Cardiovascular Multi-dimensional Observational Investigation of the Use of PCSK9 Inhibitors (cvMOBIUS)". cvMOBIUS is a North American registry of patients with ASCVD aimed at understanding patterns of care in ASCVD while evaluating the real world effectiveness of PCSK9 inhibitors.
What is the current status of trial NCT04197453?
This trial is currently terminated. The enrollment target is 752 participants. The study started on 2019-12-06. Estimated completion is 2020-12-21.
Who is sponsoring clinical trial NCT04197453?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.